This April marked five years since public health transitioned from the NHS to local authorities in England. A recent Association of Directors of Public Health survey found 67% of respondents strongly or somewhat agreed that the move had weakened the relationship between public health and the NHS. However, a recognised feature of the transfer has […]
Clinicians in the UK are unable to offer their best service as a result of overwhelming demand and reduced staffing […]
Seventy years ago, the NHS was created with bold principles at its core, two of which are particularly relevant at this time: that it be free at the point of delivery, and that it be based on clinical need, not ability to pay. The creeping introduction and now extension of healthcare charging is a direct […]
As both healthcare systems celebrate landmark years, they also share similar threats to their continued survival […]
Progress in child health depends on research—an important message to remember as we face the imminent departure of the UK from the EU […]
Recent high profile cases against doctors have brought the offence of gross negligence manslaughter (GNM) into sharp focus and created an unprecedented level of debate and fear across the profession. In Scotland the offence does not exist—so what is the comparable offence in Scotland and is it better suited to determining the culpability of a […]
One of the successes of health workers concerned with climate change has been to get climate change framed as a health issue as well as an environmental issue […]
We need to find a way to deal with the touch-point between professional judgement and consumer sovereignty […]
An evaluation of the UK’s pathology capacity by Cancer Research UK (CRUK) has identified that over the next 5-10 years “there is likely to be a severe crisis.” The report highlights a 4.5% year-on-year increase in the number and complexity of histopathology requests since 2007/08; the majority of which are for the investigation of cancer. […]
It is comparatively easy to find funding for the randomised trials that may or may not show the effectiveness of innovations, but much harder to fund scale-up […]